Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


José Luis Lázaro-Martínez has a total of 402 co-authors. Here are the top co-authors by number of shared publications:

  • Francisco Javier Álvaro-Afonso

    Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain

    82 shared publications
  • Yolanda García-Álvarez

    Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain

    68 shared publications
  • Javier Aragón-Sánchez

    Department of Surgery, Diabetic Foot Unit, La Paloma Hospital, Las Palmas de Gran Canaria, Spain

    50 shared publications
  • Mateo López-Moral

    Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain

    48 shared publications
  • Aroa Tardáguila-García

    Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, 28040 Madrid, Spain

    45 shared publications
  • Esther García-Morales

    Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, 28040 Madrid, Spain

    35 shared publications

Latest Publications

  • Open Access

    The Effectiveness of Orthopaedic Insoles in Reducing Plantar Pressure and Preventing the Onset of First-Time or the Recurrence of Foot Ulcers in Diabetic Patients—A Systematic Review

    by Marta Izquierdo-Renau, Esther García-Morales, Iván Julián-Rochina, Raquel Alabau-Dasi, Enrique Sanchis-Sales, José Luis Lázaro-Martínez, Aroa Tardáguila-García

    Background/Objectives: Prevention of the first diabetic foot ulcer and subsequent ulcer recurrence is a key priority in diabetes care. Foot orthoses are used to redistribute plantar pressure and protect high-risk areas; however, their effectiveness in preventing ulceration remains uncertain. This systematic review aimed to evaluate the effectiveness of foot orthoses in modifying plantar pressure and preventing first or recurrent diabetic foot ulcers. Methods: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. PubMed, Web of Science, and Embase were searched. Studies were selected according to predefined eligibility criteria related to publication type, language, patient characteristics, and the use of foot orthoses. Methodological quality and risk of bias were assessed using Joanna Briggs Institute critical appraisal tools. Results: The search identified 963 records. After screening and full-text assessment, 12 articles met the inclusion criteria; one additional article was identified and included subsequently, resulting in 13 studies. Overall, foot orthoses reduced plantar pressure, particularly beneath the metatarsal heads. However, the available evidence directly assessing the prevention of first or recurrent diabetic foot ulceration was limited. Conclusions: Foot orthoses may contribute to diabetic foot ulcer prevention by reducing plantar pressure in high-risk areas. Nevertheless, further well-designed longitudinal studies are needed to determine whether these biomechanical improvements translate into a reduction in ulcer incidence and recurrence.

  • Open Access

    The Foot Skin Microbiome in Diabetes Mellitus: Transitional Dysbiosis, Ulceration, and Precision Microbiome-Based Therapeutics: A Narrative Review

    by Iván Julián-Rochina, Mateo López-Moral, Esther García-Morales, Marta Izquierdo-Renau, José David Piñeiro-Ramos, José Luis Lázaro-Martínez

    Diabetic foot syndrome (DFS) is a severe complication affecting millions of people worldwide, yet its clinical management remains predominantly reactive, focusing on established ulcers rather than early preventive measures. Although the role of the cutaneous microbiome in chronic wounds is recognized, longitudinal ecological shifts in the skin of the foot throughout the progression of diabetes mellitus remain underexplored. This structured narrative review evaluates transitional microbial dynamics from intact skin through to active ulceration and explores emerging microbiome-targeted therapies. Based on a structured literature search of PubMed, Scopus, and Web of Science, complemented by citation searching, and a narrative synthesis of 32 selected publications, current evidence suggests that diabetes-associated changes in the cutaneous microbiome involve heterogeneous alterations in microbial diversity and composition, which vary according to microbial community, anatomical location, and clinical status. DFS progression involves a profound ecological collapse, characterized by depletion of protective commensals (e.g., Staphylococcus epidermidis) and the predominance of virulent Staphylococcus aureus lineages alongside Gram-negative anaerobes. Consequently, precision interventions such as topical probiotics, synbiotics, and bacteriophage therapy have substantial potential to disrupt recalcitrant biofilms and reprogram host immunity toward pro-regenerative phenotypes. Ultimately, recognizing the skin as a primary target organ in diabetes mellitus highlights the need to shift DFS management toward a proactive framework. Validating these microbiome-modulating therapies through standardized clinical trials is crucial to restoring host-microbiota symbiosis and ultimately preventing lower-extremity amputations.

  • Effect of a Structured Preventive Intervention on Diabetic Foot Outcomes: A Randomized Controlled Trial with Qualitative Insights

    by Sol Tejeda-Ramírez, Aroa Tardáguila-García, Laura Palacios-Abril, Cristina De Benito-Morán, Esther García-Morales, José Luis Lázaro-Martínez

    To evaluate the effectiveness of a specialist-led structured preventive educational intervention on diabetic foot outcomes in adults at risk of diabetic foot complications. Study design: Parallel-group randomized controlled trial with an embedded qualitative component. Setting: Specialised diabetic foot unit within a public healthcare setting. Participants: Adults with diabetes classified at any ulceration risk level according to the International Working Group on the Diabetic Foot were randomly assigned to the intervention or control group. Forty-two participants completed the 6-month follow-up. Interventions: The intervention group received a specialist-led structured preventive educational programme comprising two structured group sessions in addition to standard podiatric care. The control group received standard podiatric care alone. Results: Forty-two participants completed the study. No diabetic foot ulceration occurred during the 6-month follow-up. Participants receiving the educational intervention improved disease-related knowledge, preventive self-care behaviours, and foot skin quality. Qualitative findings indicated greater confidence, emotional support, and engagement in preventive self-care. Conclusions: A specialist-led structured preventive educational intervention improved disease-related knowledge, preventive self-care behaviours, and foot skin quality in adults at risk of diabetic foot complications. These findings support the integration of structured education into routine preventive diabetic foot care.

  • Offloading Matters: A Meta-Research Audit of Mechanical Validity in Trials Supporting the 2023 IWGDF Recommendations on Interventions to Enhance Healing of Foot Ulcers in People with DM

    by Mariana Alves Bandeira, Yolanda Garcia Alvarez, Mateo López Moral, Sebastián Flores Escobar, José Luis Lázaro Martinez, Vera Lucia Conceição De Gouveia Santos

    Aim: This study aimed to evaluate and quantify the mechanical offloading methodological robustness of RCTs cited in the 2023 IWGDF interventions to enhance healing recommendations. Methods: A meta-research audit was conducted on 43 RCTs referenced in IWGDF guideline. A predefined framework assessed study characteristics, offloading system, adherence and activity monitoring, protocol implementation and symmetry, and mechanical offloading confounding risks. Trials were evaluated using a 10-point Offloading Quality Score (OQS), scale. Descriptive analyses and exploratory statistical tests) were performed. Results: The mean OQS was 2.07 (SD ± 2.83), with a median of 0 (IQR 0-4). Twenty-seven trials (62.79%) scored ≤2/10, while only three (7%) achieved scores ≥8/10. Offloading strategies were insufficiently described in 81.4% of studies, and adherence monitoring was absent in 88.4% of trials. Non-removable offloading devices were used in 7% of studies and were positively associated with higher OQS in regression analysis (β = 0.82, p < 0.001). Conclusions: Most RCTs underpinning the 2023 IWGDF recommendations demonstrate limited reporting and standardization of mechanical offloading. This may introduce unmeasured variability in mechanical exposure and could affect the interpretation of treatment effects. Future trials should standardize offloading protocols to improve internal validity and DFU research interpretation.


  • Open Access

    One-Year Evolution of Macrovascular and Microvascular Parameters After Endovascular Revascularization in Diabetic Foot Ulcers: A Prospective Multicenter Study

    by Israel Anguiano-Marcos, Sebastián Flores-Escobar, Yolanda García-Álvarez, Aroa Tardáguila-García, José Luis Lázaro-Martínez, Francisco Javier Álvaro-Afonso

    Background: This study aimed to characterize the one-year longitudinal evolution of macrovascular and microvascular parameters following endovascular revascularization in patients with ischemic or neuroischemic diabetic foot ulcers (DFUs). Associations between early post-revascularization vascular parameters and wound-healing outcomes were evaluated as secondary exploratory analyses. Methods: A prospective multicenter longitudinal study included 27 ischemic or neuroischemic DFUs undergoing endovascular revascularization. Patients were followed for 12 months with serial assessments of ankle systolic pressure (AP), toe systolic pressure (TP), ankle-brachial pressure index (ABPI), toe-brachial pressure index (TBPI), transcutaneous oxygen pressure (TcPO2), and skin perfusion pressure (SPP). Secondary exploratory analyses evaluated associations between early vascular parameters and wound-healing outcomes. Results: Twenty-six ulcers (96.3%) achieved complete healing, with no major amputations or deaths during follow-up. AP, TP, ABPI, and TBPI improved significantly over 12 months (all p < 0.001), whereas TcPO2 showed a significant overall longitudinal effect (p = 0.010) despite greater variability, and SPP remained unchanged (p = 0.177). Exploratory secondary analyses suggested that higher AP at four weeks after revascularization was associated with shorter healing time (ρ = −0.451, p = 0.024), while higher TcPO2 values were observed in ulcers with early wound healing (p = 0.040). Conclusions: Macrovascular and microvascular parameters exhibit distinct recovery patterns following endovascular revascularization. Longitudinal assessment of both vascular compartments may provide complementary information for monitoring vascular recovery. The exploratory associations observed between early vascular parameters and wound-healing outcomes warrant confirmation in larger adequately powered studies.

  • Open Access

    The Role of Infrared Thermography in the Diagnosis and Monitoring of Diabetic Foot Infection: A Systematic Review

    by Carmen Cantarero-Lozano, Aroa Tardáguila-García, Esther García-Morales, Yolanda García-Álvarez, David Navarro-Pérez, José Luis Lázaro-Martínez

    Background: Diabetic foot infection (DFI) is one of the most frequent diabetes-related complications requiring hospitalisation and is a major contributor to lower-extremity amputation. Infrared thermography has emerged as a non-invasive diagnostic tool capable of detecting temperature changes associated with inflammatory and infectious processes. This systematic review aimed to evaluate the role of thermography in the diagnosis and monitoring of diabetic foot infection. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was followed. Risk of bias and methodological quality were assessed using design-specific validated tools, including QUADAS-2 for diagnostic and detection studies and Joanna Briggs Institute critical appraisal checklists for cohort and case-series studies. Original studies evaluating the use of thermography in patients with diabetic foot infection were included. Two authors independently performed study selection, data extraction, and methodological assessment. Results: Six studies met the inclusion criteria, comprising a total of 552 participants with type 1 or type 2 diabetes mellitus. Four observational studies and two pilot studies were included. Increased local skin temperature was consistently associated with acute diabetic foot complications and infection. Several studies identified a temperature difference of approximately 2.2 °C between contralateral foot regions as a clinically relevant threshold for detecting diabetic foot complications. However, no significant relationship was found between plantar thermal asymmetry and the severity or progression of infected diabetic foot ulcers. All included studies presented a level of evidence of 4 and a grade of recommendation of C. Conclusions: Infrared thermography appears to be a promising adjunctive tool for the early detection of diabetic foot infection. However, current evidence does not support its routine use for monitoring infection severity, treatment response, or prognosis, and further prospective studies are required before these applications can be recommended.

  • Open Access

    Cutaneous Manifestations as a Clinical Screening Index for Diabetic Microvascular Involvement: A Pilot Cross-Sectional Study

    by Laura Palacios-Abril, Aroa Tardáguila-García, Francisco Javier Álvaro-Afonso, Sol Tejeda-Ramírez, Yolanda García-Álvarez, José Luis Lázaro-Martínez

    Background and objectives: Diabetic microangiopathy is a frequent complication of diabetes mellitus, and its early identification remains challenging, particularly in resource-limited settings. This study aimed to develop a simple clinical scoring system based on cutaneous manifestations to estimate the risk of microangiopathy. Methods: An observational cross-sectional pilot study was conducted in 30 adults with diabetes mellitus attending a specialized diabetic foot unit. Lower-limb cutaneous manifestations (xerosis, absence of hair, hyperpigmentation, nail-plate thickening, skin atrophy and hypertrophy) were assessed during physical examination. Cutaneous findings significantly associated with clinically established microangiopathy were incorporated into a preliminary clinical screening index. Its discriminative ability was evaluated using receiver operating characteristic (ROC) analysis. As a secondary exploratory analysis, the relationship between the index and transcutaneous oxygen pressure (TcPO2) was investigated. Results: Five cutaneous manifestations were included in the final clinical screening index. The index demonstrated excellent discriminative ability for identifying clinically established microangiopathy (AUC = 0.95; 95% CI: 0.88–1.00). A cut-off value of ≥4 points yielded a sensitivity of 76.2% and a specificity of 100%. Higher index scores showed a trend towards lower TcPO2 values and a greater frequency of reduced tissue oxygenation, although these exploratory associations were not statistically significant. Conclusions: The proposed score shows promising discriminative performance. Although physiological associations were not statistically significant, observed trends support its potential clinical relevance. Further validation in larger cohorts is required.

  • Open Access

    Association Between Physical Activity and Peripheral Arterial Disease in Patients with Diabetes: A Multicentre Cross-Sectional Study

    by Laura Palacios-Abril, Aroa Tardáguila-García, Francisco Javier Álvaro-Afonso, Sol Tejeda-Ramírez, Mateo López-Moral, José Luis Lázaro-Martínez

    Background and Objectives: Physical inactivity is a modifiable risk factor for vascular complications in individuals with diabetes mellitus. The aim of this study was to evaluate the predictive capacity of physical activity level for peripheral arterial disease (PAD) in patients with diabetes. Methods: A multicentre cross-sectional study was conducted in adults with diabetes undergoing vascular screening. Physical activity was assessed using the Spanish short version of the Minnesota Leisure-Time Physical Activity Questionnaire (VREM), with energy expenditure expressed as metabolic equivalents (MET-min/14 days). PAD was defined according to standard vascular criteria. Analyses included bivariate tests, Spearman correlation, multivariable logistic regression, and receiver operating characteristic (ROC) curve analysis. Results: Fifty-four participants were included, with a mean energy expenditure of 4031.8 ± 3986.9 MET-min/14 days. Physical activity was inversely correlated with PAD (ρ = −0.380; p = 0.005). Participants without PAD had significantly higher activity levels than those with PAD (p = 0.006). After adjustment for age, body mass index, glycated haemoglobin, and diabetes duration, higher physical activity remained independently associated with lower odds of PAD (OR = 0.621; 95% CI: 0.392–0.983; p = 0.042). The model showed good discrimination (AUC = 0.840). Conclusions: Higher leisure-time physical activity is associated with a reduced likelihood of PAD in individuals with diabetes, although the findings should be interpreted cautiously due to the study design and sample size.

  • Transcutaneous CO 2 Therapy Improves Tissue Oxygenation, Ulcer Healing and Pain in Recurrent Hard-to-Heal Diabetic Foot Ulcers: A Randomized Controlled Trial

    by Miloš Potkonjak, Bernardka Ančimer, José Luis Lázaro-Martínez, Marianne Brodmann, Nikolaos Papanas, Igor Frangež

    This trial evaluates whether transcutaneous gaseous carbon dioxide therapy (CO 2 therapy) combined with standard of care (SOC) improves healing of hard-to-heal recurrent diabetic foot ulcers (DFUs) compared with SOC alone. A total of 30 participants with recurrent hard-to-heal DFUs were included and randomized 1:1 to an intervention (CO 2 therapy plus SOC) or a control group (SOC only). The intervention consisted of 20 daily 50-minute CO 2 therapy sessions over 4 weeks. After 4 weeks, 46.7% of ulcers in the intervention group were completely healed, versus 0% in the control group (p = 0.005). The intervention group showed a median area reduction of 85.7% (IQR 54.9–100) compared to 17.2% (IQR 0.88–33.5) in controls (p < 0.001), with significantly better Falanga wound-bed scores (p < 0.001). The intervention group demonstrated a significant relative increase in StO 2 (29.6 ± 19.6%), whereas the control group exhibited a decrease (-2.2 ± 6.9%), resulting in a between-group difference of 31.8% (95% CI 20.5%–43.0%; p < 0.001). Pain intensity significantly decreased in the intervention group only (p = 0.002). This trial suggests that CO 2 therapy in combination with SOC is superior to SOC alone in healing recurrent, hard-to-heal DFUs.

  • Er:YAG laser Therapy for Diabetic Foot Ulcers: A Pilot Study with Hyperspectral Imaging Assessment

    by Sebastián Flores-Escobar, Francisco Javier Álvaro-Afonso, Yolanda García-Álvarez, Mateo López-Moral, Irene Sanz-Corbalán, José Luis Lázaro-Martínez

    Diabetic foot ulcers (DFU) are associated with impaired wound healing and high morbidity. Er:YAG laser therapy has been proposed as an adjunctive treatment due to its ablative and biostimulatory properties. The aim of this study was to explore the feasibility and preliminary clinical and physiological responses to adjunctive Er:YAG laser therapy in DFUs using hyperspectral imaging (HSI). A pilot study including five patients with DFU was conducted. All patients received Er:YAG laser therapy once weekly for 8 weeks in addition to standard of care. Clinical outcomes included wound area and wound-bed quality assessed using the Wollina wound score. Physiological responses were evaluated using HSI-derived parameters, including tissue oxygen saturation, oxyhemoglobin, deoxyhemoglobin, and total hemoglobin, measured before and after laser treatment sessions. Wound area showed a progressive reduction during follow-up, with a mean percentage wound area reduction of 33.06 ± 44.9% at week 8. Wound-bed condition improved significantly over time, with the Wollina wound score increasing from a median of 5 at baseline to 7 at week 8 (p = 0.024). HSI analysis demonstrated significant and sustained increases in THb and OxyHb at weeks 4 and 8 compared with baseline values (p < 0.05), indicating improved tissue perfusion and oxygen delivery. These preliminary findings suggest that adjunctive Er:YAG laser therapy was feasible and showed promising improvements in wound-bed quality and perfusion-related HSI parameters, alongside clinically meaningful wound size reduction. HSI appears to be a promising tool for the objective assessment of physiological responses to therapy.